Company intelligence / Profile preview

Immagina Biotechnology

Trento/Mattarello or Pergine Valsugana, Trentino-Alto Adige/Südtirol, Italyimmaginabiotech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Immagina Biotechnology develops innovative products and services focused on the study of RNA biology and translation mechanisms. Their proprietary ribosome-centric platforms enable researchers to profile active translation events at high resolution. Technologies such as RiboLace™, AHARIBO systems, DART-RNAseq, nano-tRNAseq kits, and the MARTIAN bioinformatics suite support applications in drug discovery research, disease mechanism elucidation, diagnostics development, translatomics/proteogenomics studies. The company collaborates with academic labs globally to advance knowledge in this field.

Therapeutic areas: Rare Diseases
Modalities: RNA therapy (enabling technology)Small molecule (enabling technology for ribosome-targeting compounds)Diagnostic biomarker platform (research-use only and clinical research tools)Data analysis platform (bioinformatics suite for translatomics)
Industry: Drug Discovery Services

Partnerships

Collaborations with academic labs such as eRIS Lab led by Gabriella Viero; broader "Immagina & Friends" network includes global scientific advisors/collaborators

Beyond the preview

Go deeper on Immagina Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immagina Biotechnology.

Explore the full profile